Abstract
The Flare instrument (FI) is a French self-administrated questionnaire used to identify flares in disease activity in patients with rheumatoid arthritis. In addition to a total score, the FI has two subscales: one relating to joint symptoms and one relating to general symptoms. The objective of this study was to translate and adapt the French FI into Danish and to determine the reliability of the FI in a consecutive cohort of patients with RA. The FI was translated according to international guidelines, tested among 10 patients and 5 health professionals, and adapted. Test-retest reliability was determined by the standard error of the measurement (SEM) and the intra class correlation coefficients (ICC). The FI was administered to 50 patients with rheumatoid arthritis from an outpatient clinic of a university hospital and re-administered after 10 days. The patients had a mean age of 65.3 years (SD 12.0) and mean disease duration of 18.1 years (range 2–47 years). We found an excellent reliability with ICC higher than 0.95 and SEM between 0.44 and 0.63. Best reliability was found in the total FI score. Thus, the results of the present study show that the FI is a feasible and reliable tool for evaluation of flares in patients with rheumatoid arthritis.
Similar content being viewed by others
References
National Collaborating Centre for Chronic Conditions (UK) (2009) Rheumatoid arthritis: national clinical guideline for management and treatment in adults
Rahman MU, Strusberg I, Geusens P et al (2007) Double-blinded infliximab dose escalation in patients with rheumatoid arthritis. Ann Rheum Dis 66:1233–1238
Smolen JS, Keystone EC, Emery P et al (2007) Consensus statement on the use of rituximab in patients with rheumatoid arthritis. Ann Rheum Dis 66:143–150
Yazici Y, Erkan D, Kulman I, Belostocki K, Harrison MJ (2002) Decreased flares of rheumatoid arthritis during the first year of etanercept treatment: further evidence of clinical effectiveness in the “real world”. Ann Rheum Dis 61:638–640
Bingham CO III, Pohl C, Woodworth TG (2009) Developing a standardized definition for disease “flare” in rheumatoid arthritis (OMERACT 9 special interest group). J Rheumatol 36:2335–2341
Prevoo ML, van ’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48
Bykerk VP, Lie E, Bartlett SJ et al (2014) Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare Workshop. J Rheumatol 41:799–809
Berthelot JM, De Bandt M, Morel J et al (2012) A tool to identify recent or present rheumatoid arthritis flare from both patient and physician perspectives: the ‘FLARE’ instrument. Ann Rheum Dis 71:1110–1116
Great Britain. Department of Health (2010) Equity and excellence: liberating the NHS. Stationery Office, Norwich
Aletaha D, Neogi T, Silman AJ et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League against rheumatism collaborative initiative. Ann Rheum Dis 69:1580–1588
Guillemin F, Bombardier C, Beaton D (1993) Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 46:1417–1432
Mokkink LB, Terwee CB, Patrick DL et al (2010) The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res 19:539–549
Terwee CB, Bot SD, de Boer MR et al (2007) Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 60:34–42
Fayers PM, Machin D (2007) Quality of life: the assessment, analysis and interpretation of patient-reported outcomes. Wiley, Chichester
Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1:307–310
Streiner DL (2003) Starting at the beginning: an introduction to coefficient alpha and internal consistency. J Pers Assess 80:99–103
Hopkins WG (2000) Measures of reliability in sports medicine and science. Sports Med 30:1–15
Sokka T, Makinen H (2009) Drug management of early rheumatoid arthritis—2008. Best Pract Res Clin Rheumatol 23:93–102
Sokka T, Toloza S, Cutolo M et al (2009) Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study. Arthritis Res Ther 11:R7
Scholtes VA, Terwee CB, Poolman RW (2011) What makes a measurement instrument valid and reliable? Injury 42:236–240
Acknowledgments
We highly appreciate the collaboration with Professor Bruno Fautrel, Department of Rheumatology, Pitié-Salpétriêre Hospital, Paris Cedex, France, who allowed us to translate the FI questionnaire from French into Danish and to carry out the first reliability study.
Financial support was provided by the Clinical Institute of Medicine, Aarhus University.
Conflict of interest
None
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(PDF 578 kb)
Appendix 1
Appendix 1
Flare spørgeskema
De følgende spørgsmål drejer sig om, hvordan leddegigten har præget din hverdag inden for de sidste 3 måneder eller siden sidste konsultation.
Anfør venligst i hvilken grad du er enig eller uenig i nedenstående udsagn ved at sætte kryds i det felt, der svarer bedst til din mening.
Der er ingen rigtige eller forkerte svar. Vi er interesserede i din personlige mening.
Du bedes venligst besvare alle spørgsmål
Inden for de seneste 3 måneder (eller siden den sidste konsultation)
Fig W1: Translation of the Flare instrument, a self-administered questionnaire to measure disease activity in RA patients
Rights and permissions
About this article
Cite this article
Maribo, T., de Thurah, A. & Stengaard-Pedersen, K. Patient-self assessment of flare in rheumatoid arthritis: translation and reliability of the Flare instrument. Clin Rheumatol 35, 1053–1058 (2016). https://doi.org/10.1007/s10067-014-2848-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-014-2848-z